The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.

De Iuliis F, Taglieri L, Salerno G, Giuffrida A, Milana B, Giantulli S, Carradori S, Silvestri I, Scarpa S

Open source

DOI
10.1007/s10637-016-0345-8
Published
2016 Aug
Container
Investigational new drugs
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10637-016-0345-8,
  title = {The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.},
  author = {De Iuliis F and Taglieri L and Salerno G and Giuffrida A and Milana B and Giantulli S and Carradori S and Silvestri I and Scarpa S},
  year = {2016},
  journal = {Investigational new drugs},
  doi = {10.1007/s10637-016-0345-8},
  url = {https://doi.org/10.1007/s10637-016-0345-8}
}

RIS

TY  - JOUR
TI  - The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.
AU  - De Iuliis F
AU  - Taglieri L
AU  - Salerno G
AU  - Giuffrida A
AU  - Milana B
AU  - Giantulli S
AU  - Carradori S
AU  - Silvestri I
AU  - Scarpa S
PY  - 2016
JO  - Investigational new drugs
DO  - 10.1007/s10637-016-0345-8
UR  - https://doi.org/10.1007/s10637-016-0345-8
ER  - 

APA

F, D. I., L, T., G, S., A, G., B, M., S, G., S, C., I, S., & S, S. (2016). The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.. Investigational new drugs. https://doi.org/10.1007/s10637-016-0345-8

Source records